Current position:Home >Product >
Glycine, N-[2-(hydroxyimino)-1-oxopropyl]-, monopotassium salt, (E)-
Glycine, N-[2-(hydroxyimino)-1-oxopropyl]-, monopotassium salt, (E)-(125160-37-4)
- Name: Glycine, N-[2-(hydroxyimino)-1-oxopropyl]-, monopotassium salt, (E)-
- Synonyms:
- Molecular Formula:C5H8N2O4.K
- Molecular Weight:
- CAS Registry Number:125160-37-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.125160-37-4 Glycine, N-[2-(hydroxyimino)-1-oxopropyl]-, monopotassium salt, (E)-
Assay:99.90% Appearance:solid or liquid Package:Foil bag; Drum; Plastic bottle Storage:in sealed air resistant place Transportation:by sea or air Application:Pharma;Industry;Agricultural
Min. Order:0
Supplier:Kono Chem Co.,Ltd [
China (Mainland)]
Other Product
- 125144-00-5/L-Glutamine, L-cysteinyl-L-seryl-L-asparaginyl-L-seryl-L-seryl-L-seryl-L-seryl-L-glutaminyl -L-phenylalanyl-L-glutaminyl-L-isoleucyl-L-histidylglycyl-L-prolyl-L-arginyl-
- 125144-04-9/1H-Pyrazole-3-carbonitrile,5-amino-(9CI)
- 125145-03-1/2-Propenoic acid, 3-(diphenylphosphino)-, (Z)-
- 125145-04-2/2-Propenoic acid, 3-(diphenylphosphino)-, (E)-
- 125151-51-1/2-Hepten-1-ol, 7-chloro-4,4,5,5,6,6,7,7-octafluoro-2-iodo-, (E)-
- 125151-52-2/2-Hepten-1-ol, 7-chloro-4,4,5,5,6,6,7,7-octafluoro-2-iodo-, (Z)-
- 125151-57-7/3-Butyn-2-ol, 2-methyl-4-[4-(octyloxy)phenyl]-
- 125151-58-8/3-Butyn-2-ol, 2-methyl-4-[4-(nonyloxy)phenyl]-
- 125151-60-2/3-Butyn-2-ol, 2-methyl-4-[4-(undecyloxy)phenyl]-
- 125151-61-3/3-Butyn-2-ol, 4-[4-(dodecyloxy)phenyl]-2-methyl-
- 125151-86-2/1,3-Propanediamine, N,N'-bis[2-(dimethylamino)ethyl]-
- 12515-19-4/Cadmium, compd. with nickel (5:1)
- 125155-38-6/2-Hexyn-1-ol, 4-methyl-
- 125158-07-8/1,3,2-Oxathiaphospholane, 2-phenoxy-, 2-sulfide
- 125159-34-4/1,2-Benzenediamine, 4-[(4-aminophenyl)thio]-
- 125159-35-5/3,5-Isoxazoledicarboxylic acid, 4,5-dihydro-
- 125160-22-7/1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[2-(phenylthio)ethenyl]-, (E)-
- 125160-23-8/1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[2-(phenylsulfinyl)ethenyl]-, (E)-
- 125160-24-9/1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[2-(phenylsulfonyl)ethenyl]-, (E)-
- 125160-37-4/Glycine, N-[2-(hydroxyimino)-1-oxopropyl]-, monopotassium salt, (E)-
- 12516-17-5/Cobalt, compd. with indium (1:2)
- 125161-81-1/Carbamic acid, [(2R,3R)-2,3,4,5-tetrahydro-4-oxo-2-phenyl-1,5-benzothiazepin-3-yl]-, phenylmethyl ester, rel-
- 125162-08-5/Carbamic acid, [(2R,3S)-2,3,4,5-tetrahydro-4-oxo-2-(2-thienyl)-1,5-benzothiazepin-3-yl]- , phenylmethyl ester, rel-
- 125162-48-3/2H-1-Benzazepin-2-one, 3-amino-1,3,4,5-tetrahydro-4-phenyl-, (3R,4S)-rel-
- 125162-78-9/1,4,8,11-Tetraazacyclotetradecane-1-propanamine
- 125163-18-0/3-Pyridinecarboxylic acid, 1,2-dihydro-5-methyl-2-thioxo-
- 125163-27-1/Pyridine, 3-bromo-2,6-dimethyl-4-(methylthio)-, 1-oxide
- 125163-29-3/Pyridine, 3-bromo-2,6-dimethyl-4-(methylthio)-
- 125164-82-1/Silane, [3,5-cyclohexadiene-1,2-diylbis(oxy)]bis[(1,1-dimethylethyl)dimethyl-, cis-
- 125167-54-6/Phenol, 4,4'-(1,1,3,3-tetraphenyl-1,3-disiloxanediyl)bis-